In an era where drug-resistant infections pose a severe threat to global health, the emergence of a new class of antibiotics heralds a potential breakthrough in the fight against microbial resistance.Kinvard Bio, an innovative startup founded at Harvard University, is pioneering this new class designed specifically to tackle the challenge of antibiotic resistance head-on.